Wikisage, the free encyclopedia of the second generation, is digital heritage

Epilepsy: Difference between revisions

From Wikisage
Jump to navigation Jump to search
m (wlink)
(KOSM)
Line 45: Line 45:
|-style="vertical-align:top; background:#ffffff;"
|-style="vertical-align:top; background:#ffffff;"
|align="left" style="background:#99ff99"|'''topiramat'''  ||
|align="left" style="background:#99ff99"|'''topiramat'''  ||
|colspan="3" | [[XR-topimaramate|xr]]
|colspan="3" | [[XR-topiramate|xr]]
|-
|-
| colspan="3" style="text-align:center; font-size:120%; background-color:#32CD32;" |  
| colspan="3" style="text-align:center; font-size:120%; background-color:#32CD32;" |  

Revision as of 17:10, 25 July 2015

Classification of ethiology could divided in four categories:

  • idiopathic epilepsy
  • symptomatic epilepsy
  • provoked epilepsy
  • cryptogenic epilepsy

[1] It is difficult to distinguish between genetic and cryptogenic syndromes.

Morbility data is difficult to interpret when WHO states 50 millions persons affect by epilepsy[2]

nonadherence appears to be associated with increased health care costs,nevertheless XR-medicine appears as strategy to overcome compliance AED [3]

Medicines

type  ,,, ,,,,
INN  Generic slow release
carbamazepine  normal xr
lamotrigine  normal xr
levetiracetam  normal xr
oxcarbazepine  ... xr
phenitoin  ... xr
valproate  xr
topiramat  xr

AED

ILAE Classification

[4] [5] A new perspective for Epileptic Disorders

Links

Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Dravet's syndrome


References

References: